Drug Approval | September 15, 2023
Strides receives tentative USFDA approval for Dolutegravir tablets
The products will be manufactured at the company's facility in Bengaluru
The products will be manufactured at the company's facility in Bengaluru
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The products will be manufactured at the company's facility in Bengaluru
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Subscribe To Our Newsletter & Stay Updated
